London hedge fund hires Citi's commodities electronic trading head
Rokos Capital is in the midst of a shake-up. The hedge fund recently announced that Matthew Sebag-Montefiore, who joined in 2018, would become its CEO, replacing former Goldman Sachs MD Mark Edwards. Shuffling has also occurred in the fund's technology team, with the addition of a veteran electronic trading specialist.
Click here to follow our new WhatsApp channel, and get instant news updates straight to your phone 📱
Ossie Manners has joined Rokos as head of systematic technology from Citi, where he was head of commodities eTrading for four years. He departed from the bank in April, and has been out of the market for three months. It's not clear whether he was impacted by Citi's mass layoffs and restructuring efforts.
Most of Manners' career has been spent at Goldman Sachs, where he worked for 15 years. He became a commodities desk strat at the bank after graduating, and became an eTrading strat lead five years later.
Rokos' founder, Chris Rokos, has a thing for Goldman Sachs alums... after all, he is one. Other recent hires include portfolio trader Abhilash Goyal, who spent eight years as a mortgage trader at Goldman.
It's not all incomings, however. Dmitry Green, a partner and co-chief risk officer, left the company last month and is now on gardening leave.
Rokos Capital appears to have had a strong start to 2024; Bloomberg reported that its macro fund was up 20.6% this year through to July. It remains to be seen if the fund can keep pace with all these internal changes.
Have a confidential story, tip, or comment you’d like to share? Contact: Telegram: @AlexMcMurray, WhatsApp: (+1 269 237 3950). Click here to fill in our anonymous form, or email editortips@efinancialcareers.com. Signal also available.
Bear with us if you leave a comment at the bottom of this article: all our comments are moderated by human beings. Sometimes these humans might be asleep, or away from their desks, so it may take a while for your comment to appear. Eventually it will – unless it’s offensive or libelous (in which case it won’t.)
